Editas Medicine, Inc. (EDIT) Description, Stock price, News & Info.

#ThinkSabio Latest News

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting. 09 Dec 2024